久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/06 | 4,065 | 4,135 | 4,040 | 4,070 | ±0 | ±0% | 229,300 |
2021/10/05 | 4,170 | 4,190 | 4,045 | 4,070 | -130 | -3.1% | 443,700 |
2021/10/04 | 4,240 | 4,250 | 4,180 | 4,200 | +30 | +0.7% | 301,100 |
2021/10/01 | 4,175 | 4,210 | 4,120 | 4,170 | -75 | -1.8% | 334,500 |
2021/09/30 | 4,225 | 4,320 | 4,220 | 4,245 | +15 | +0.4% | 305,100 |
2021/09/29 | 4,175 | 4,230 | 4,155 | 4,230 | +10 | +0.2% | 312,200 |
2021/09/28 | 4,235 | 4,260 | 4,190 | 4,220 | -60 | -1.4% | 321,100 |
2021/09/27 | 4,415 | 4,440 | 4,280 | 4,280 | -115 | -2.6% | 240,600 |
2021/09/24 | 4,320 | 4,410 | 4,320 | 4,395 | +145 | +3.4% | 373,800 |
2021/09/22 | 4,325 | 4,325 | 4,235 | 4,250 | -95 | -2.2% | 287,200 |
2021/09/21 | 4,380 | 4,395 | 4,340 | 4,345 | -70 | -1.6% | 264,100 |
2021/09/17 | 4,465 | 4,485 | 4,380 | 4,415 | +20 | +0.5% | 393,600 |
2021/09/16 | 4,440 | 4,440 | 4,375 | 4,395 | -5 | -0.1% | 227,100 |
2021/09/15 | 4,460 | 4,475 | 4,400 | 4,400 | -120 | -2.7% | 298,400 |
2021/09/14 | 4,515 | 4,530 | 4,480 | 4,520 | +5 | +0.1% | 206,200 |
2021/09/13 | 4,500 | 4,520 | 4,470 | 4,515 | +5 | +0.1% | 151,600 |
2021/09/10 | 4,515 | 4,535 | 4,465 | 4,510 | -25 | -0.6% | 293,100 |
2021/09/09 | 4,630 | 4,645 | 4,530 | 4,535 | -90 | -1.9% | 232,300 |
2021/09/08 | 4,620 | 4,675 | 4,600 | 4,625 | +20 | +0.4% | 249,000 |
2021/09/07 | 4,630 | 4,655 | 4,590 | 4,605 | +5 | +0.1% | 208,500 |
2021/09/06 | 4,675 | 4,700 | 4,560 | 4,600 | -10 | -0.2% | 260,400 |
2021/09/03 | 4,480 | 4,625 | 4,470 | 4,610 | +180 | +4.1% | 311,900 |
2021/09/02 | 4,470 | 4,515 | 4,405 | 4,430 | -35 | -0.8% | 235,500 |
2021/09/01 | 4,500 | 4,545 | 4,420 | 4,465 | +55 | +1.2% | 279,500 |
2021/08/31 | 4,380 | 4,445 | 4,330 | 4,410 | -5 | -0.1% | 293,500 |
2021/08/30 | 4,460 | 4,485 | 4,390 | 4,415 | -70 | -1.6% | 551,800 |
2021/08/27 | 4,535 | 4,575 | 4,470 | 4,485 | -80 | -1.8% | 260,300 |
2021/08/26 | 4,655 | 4,705 | 4,560 | 4,565 | -20 | -0.4% | 224,900 |
2021/08/25 | 4,505 | 4,610 | 4,495 | 4,585 | +65 | +1.4% | 214,800 |
2021/08/24 | 4,505 | 4,555 | 4,480 | 4,520 | -5 | -0.1% | 218,000 |
2021/08/23 | 4,510 | 4,590 | 4,505 | 4,525 | +65 | +1.5% | 177,400 |
2021/08/20 | 4,455 | 4,560 | 4,450 | 4,460 | +40 | +0.9% | 205,600 |
2021/08/19 | 4,385 | 4,465 | 4,380 | 4,420 | +15 | +0.3% | 204,400 |
2021/08/18 | 4,465 | 4,495 | 4,400 | 4,405 | -45 | -1% | 205,200 |
2021/08/17 | 4,490 | 4,550 | 4,450 | 4,450 | -15 | -0.3% | 162,400 |
2021/08/16 | 4,525 | 4,525 | 4,450 | 4,465 | -70 | -1.5% | 214,100 |
2021/08/13 | 4,515 | 4,590 | 4,515 | 4,535 | -60 | -1.3% | 259,900 |
2021/08/12 | 4,665 | 4,665 | 4,585 | 4,595 | -45 | -1% | 117,100 |
2021/08/11 | 4,615 | 4,660 | 4,605 | 4,640 | ±0 | ±0% | 202,000 |
2021/08/10 | 4,540 | 4,675 | 4,540 | 4,640 | +115 | +2.5% | 186,000 |
2021/08/06 | 4,565 | 4,635 | 4,505 | 4,525 | -90 | -2% | 202,900 |
2021/08/05 | 4,630 | 4,700 | 4,605 | 4,615 | -60 | -1.3% | 171,200 |
2021/08/04 | 4,775 | 4,805 | 4,660 | 4,675 | -115 | -2.4% | 205,500 |
2021/08/03 | 4,800 | 4,865 | 4,760 | 4,790 | -75 | -1.5% | 199,300 |
2021/08/02 | 4,845 | 4,920 | 4,820 | 4,865 | +90 | +1.9% | 191,100 |
2021/07/30 | 4,905 | 4,915 | 4,775 | 4,775 | -180 | -3.6% | 212,200 |
2021/07/29 | 5,050 | 5,060 | 4,945 | 4,955 | -55 | -1.1% | 133,500 |
2021/07/28 | 5,030 | 5,070 | 5,000 | 5,010 | -100 | -2% | 113,700 |
2021/07/27 | 5,160 | 5,170 | 5,070 | 5,110 | -30 | -0.6% | 156,100 |
2021/07/26 | 5,210 | 5,240 | 5,090 | 5,140 | ±0 | ±0% | 131,000 |
951~
1000
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 322,600円 | +3.6% | -15.3% | 3.84% | 9.06倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム